Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Saved in:
Bibliographic Details
Published inLeukemia research Vol. 71; pp. 55 - 59
Main Authors Papageorgiou, Sotirios G., Kotsianidis, Ioannis, Kontos, Christos K., Symeonidis, Argyris, Galanopoulos, Athanasios, Hatzimichael, Eleftheria, Poulakidas, Elias, Diamantopoulos, Panagiotis, Vassilakopoulos, Theodoros P., Zikos, Panagiotis, Papadaki, Helen, Bouronikou, Eleni, Panayiotidis, Panayiotis, Viniou, Nora-Athina, Pappa, Vasiliki
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.08.2018
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2018.07.004